Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
May 15th, 2018
10.7K views
This protocol is to recover and prepare rare target cells from a mixture with non-target background cells for molecular genetic characterization at the single-cell level. DNA quality is equal to non-treated single cells and allows for single-cell application (both screening based and targeted analysis).
Overview
This protocol outlines a method for isolating rare target cells from a mixture of non-target cells, enabling molecular genetic characterization at the single-cell level. The technique is particularly useful for analyzing circulating tumor cells in cancer patients.
Key Study Components
Area of Science
- Cell biology
- Molecular genetics
- Oncology
Background
- Isolating single cells is crucial for understanding cellular heterogeneity.
- This method allows for antibody-based isolation of single cells.
- It can be applied to various cell suspensions, including blood and tissue samples.
- Visual demonstration is essential due to the complexity of the procedure.
Purpose of Study
- To recover and prepare rare target cells for analysis.
- To enable characterization of circulating tumor cells.
- To provide insights into cellular heterogeneity.
Methods Used
- Cell suspension preparation and staining.
- Antibody-based isolation using a specialized wire.
- Micromanipulation and laser microdissection techniques.
- Whole genome amplification for genetic analysis.
Main Results
- Successful isolation of single cells from complex mixtures.
- High DNA quality suitable for downstream applications.
- Demonstrated feasibility for clinical applications in liquid biopsies.
- Provided a reliable method for studying cellular heterogeneity.
Conclusions
- This protocol enhances the ability to analyze rare cell populations.
- It has significant implications for cancer research and diagnostics.
- Future applications may include broader uses in various biological studies.
Frequently Asked Questions
What is the main advantage of this isolation technique?
The main advantage is its ability to isolate single cells for molecular genetic analysis, which is critical for understanding cellular heterogeneity.
How does this method apply to cancer research?
It allows for the characterization of circulating tumor cells, providing insights into cancer progression and treatment response.
What types of samples can this method be applied to?
This method can be applied to blood samples, cell cultures, and disassociated tissues and organs.
Why is visual demonstration important for this protocol?
Visual demonstration is crucial due to the complexity of the steps involved and the potential for cell loss during the process.
What is the significance of single-cell analysis?
Single-cell analysis provides detailed insights into cellular diversity and function, which is essential for understanding complex biological systems.
Executive Industry Relevance
Isolating rare target cells from high-background suspensions enables molecular characterization at single-cell resolution, addressing a critical bottleneck in liquid biopsy development. This capability supports target validation and mechanistic de-risking by providing genetically analyzable material from heterogeneous populations such as circulating tumor cells. The method enhances predictive confidence in early discovery by linking phenotypic isolation to downstream genomic screening.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through isolation of phenotypically defined single cells for genetic analysis.
- Operational Value: Supports biological de-risking by recovering target cells from complex mixtures for downstream molecular characterization.
Screening & Assay Development
- Scientific Value: Produces high-quality DNA from single cells suitable for whole genome amplification and subsequent screening applications.
- Operational Value: Enables preparation of validated biological systems for array-CGH, sequencing, or target-specific PCR workflows.
Translational & Preclinical Research
- Scientific Value: Facilitates continuity from discovery to preclinical validation by allowing characterization of cellular heterogeneity in disease-relevant systems.
- Operational Value: Supports risk-adjusted advancement decisions through single-cell genomic insights from patient-matched samples.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by enabling isolation of rare cells for lead identification and preclinical validation through molecular profiling.
- Discovery Biology: Supports hypothesis testing and pathway clarification by isolating subpopulations such as EpCAM-positive cells from blood or culture suspensions.
- Screening: Delivers assay-ready single cells with recoverable DNA for quantitative downstream analysis.
- Analytics: Generates amplifiable DNA products enabling copy number variation and mutation screening via array-CGH or sequencing.
- Translational Research: Connects to preclinical continuity through patient-matched cohort analysis showing improved CTC detection versus gold standard.
- Enterprise Reuse: Provides a reusable platform for isolating rare cells across blood, culture, and tissue samples.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through single-cell genomic resolution and reduction of mechanistic ambiguity in heterogeneous samples.
- Operational Value: Standardization of rare cell recovery via antibody-based capture and enzymatic detachment.
- Strategic Value: Improved go/no-go decisions by enabling early access to genetically characterized rare cell populations.
- Portfolio Impact: Risk-adjusted prioritization based on single-cell-derived genomic biomarkers from liquid biopsies.
Implementation Considerations
- Requires expertise in microscopy, micromanipulation, or laser microdissection for single-cell harvesting.
- Dependent on enzymatic release buffers and functionalized wire instrumentation for cell capture and recovery.
- Necessitates standardization across teams for consistent detachment and slide recovery rates (reported as <10% to >50% across cell lines).
- Requires adaptation considerations when applying to diverse model systems due to variable recovery efficiency.
- Practical limitation: recovery rate variability necessitates optimization for specific cell lines before reliable downstream use.
Biopharma FAQs
Why does enzymatic detachment matter for target validation workflows?
Enzymatic treatment allows recovery of captured cells from the functionalized wire without compromising DNA integrity, enabling subsequent whole genome amplification. This step is essential for transferring isolated cells to downstream molecular analysis while preserving genetic material for target validation.
How does isolating single cells via antibody capture fit the discovery pipeline?
Antibody-based isolation using EpCAM-functionalized wire enables enrichment of rare target cells from high-background suspensions, creating a purified input for single-cell analysis. This fits early discovery by providing a mechanistic link between surface phenotype and genomic characterization.
What quantitative measurements does whole genome amplification enable for screening?
Whole genome amplification produces DNA products suitable for array-CGH and sequencing, allowing detection of copy number variations and mutations at single-cell resolution. The method yields amplifiable DNA with a smear from 0.2 to >1 kb and QC-PCR products at 100, 200, 300, and 400 bp, enabling quantitative screening applications.
Why do replication requirements matter for cross-functional collaboration in rare cell studies?
Variable recovery rates (<10% to >50%) across cell lines necessitate standardized protocols to ensure reproducible isolation and slide attachment for reliable downstream analysis. Consistent recovery supports cross-functional trust in data generated from rare cell populations.
What statistical analysis capabilities are required before implementing single-cell WGA in target validation?
Implementation requires quality control metrics such as the 4plex QC-PCR (100, 200, 300, 400 bp) to confirm amplification success, with samples showing fewer than three bands excluded. This ensures statistical confidence in downstream genomic data before use in target validation pipelines.
Chapters in this video
0:05
Title
1:28
Preparation of Target Cells
2:41
Charging the Wire
3:27
Counting Cells on the Wire
4:03
Detachment and Recovery of Target Cells
5:25
Single-cell Sampling Using Micromanipulation
6:37
Single-cell Sampling Using Laser Microdissection
7:47
Results: Use of Functionalized Wire for Ex Vivo Characterization and Genomic Analysis at Single Cell Level
8:59
Conclusion
